Leading Pharmaceutical Innovation
Title | Leading Pharmaceutical Innovation PDF eBook |
Author | Oliver Gassmann |
Publisher | Springer Science & Business Media |
Total Pages | 184 |
Release | 2013-06-05 |
Genre | Business & Economics |
ISBN | 3540247815 |
Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade. This book investigates and highlights a set of proactive strategies. The authors focus on three sources of pharmaceutical innovation: new management methods, new technologies, and new forms of internationalization. Their findings are illustrated in the case of the Swiss pharmaceutical industry, the leading exporter of pharmaceutical products in percentage of GDP, and some of its main pharmaceutical firms such as Novartis and Hoffmann-La Roche.
Leading Pharmaceutical Innovation
Title | Leading Pharmaceutical Innovation PDF eBook |
Author | Oliver Gassmann |
Publisher | Springer |
Total Pages | 179 |
Release | 2018-05-10 |
Genre | Business & Economics |
ISBN | 3319668331 |
Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade. This book investigates and highlights a set of proactive strategies, aimed at generating sustainable competitive advantage for its protagonists based on value-generating business practices. We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of internationalisation, such as outside-in innovation in the early phases of R&D.
Leading Pharmaceutical Innovation
Title | Leading Pharmaceutical Innovation PDF eBook |
Author | Oliver Gassmann |
Publisher | |
Total Pages | 192 |
Release | 2014-01-15 |
Genre | |
ISBN | 9783662122181 |
Pharmaceutical Innovation
Title | Pharmaceutical Innovation PDF eBook |
Author | Ralph Landau |
Publisher | Chemical Heritage Foundation |
Total Pages | 442 |
Release | 1999 |
Genre | Business & Economics |
ISBN | 9780941901215 |
Documents how science has provided an astonishing array of medicines for coping with human ailments. This volume addresses industry leaders, economic influences, and the development of individual products. It is suitable for policy makers, economists, corporate executives, research managers, and historians of science, technology, and medicine.
Value Creation in the Pharmaceutical Industry
Title | Value Creation in the Pharmaceutical Industry PDF eBook |
Author | Alexander Schuhmacher |
Publisher | John Wiley & Sons |
Total Pages | 508 |
Release | 2016-01-12 |
Genre | Science |
ISBN | 3527693416 |
This practical guide for advanced students and decision-makers in the pharma and biotech industry presents key success factors in R&D along with value creators in pharmaceutical innovation. A team of editors and authors with extensive experience in academia and industry and at some of the most prestigious business schools in Europe discusses in detail the innovation process in pharma as well as common and new research and innovation strategies. In doing so, they cover collaboration and partnerships, open innovation, biopharmaceuticals, translational medicine, good manufacturing practice, regulatory affairs, and portfolio management. Each chapter covers controversial aspects of recent developments in the pharmaceutical industry, with the aim of stimulating productive debates on the most effective and efficient innovation processes. A must-have for young professionals and MBA students preparing to enter R&D in pharma or biotech as well as for students on a combined BA/biomedical and natural sciences program.
Innovation and Marketing in the Pharmaceutical Industry
Title | Innovation and Marketing in the Pharmaceutical Industry PDF eBook |
Author | Min Ding |
Publisher | Springer Science & Business Media |
Total Pages | 763 |
Release | 2013-10-31 |
Genre | Medical |
ISBN | 1461478014 |
The pharmaceutical industry is one of today’s most dynamic and complex industries, involving commercialization of cutting-edge scientific research, a huge web of stakeholders (from investors to doctors), multi-stage supply chains, fierce competition in the race to market, and a challenging regulatory environment. The stakes are high, with each new product raising the prospect of spectacular success—or failure. Worldwide revenues are approaching $1 trillion; in the U.S. alone, marketing for pharmaceutical products is, itself, a multi-billion dollar industry. In this volume, the editors showcase contributions from experts around the world to capture the state of the art in research, analysis, and practice, and covering the full spectrum of topics relating to innovation and marketing, including R&D, promotion, pricing, branding, competitive strategy, and portfolio management. Chapters include such features as: · An extensive literature review, including coverage of research from fields other than marketing · an overview of how practitioners have addressed the topic · introduction of relevant analytical tools, such as statistics and ethnographic studies · suggestions for further research by scholars and students The result is a comprehensive, state-of-the-art resource that will be of interest to researchers, policymakers, and practitioners, alike.
Pharmaceutical Innovation
Title | Pharmaceutical Innovation PDF eBook |
Author | Frank A. Sloan |
Publisher | Cambridge University Press |
Total Pages | 279 |
Release | 2007-04-30 |
Genre | Business & Economics |
ISBN | 1139465007 |
The pharmaceutical industry worldwide is a rapidly burgeoning industry contributing to growth of gross domestic product and employment. Technological change in this field has been very rapid, with many new products being introduced. For this reason in part, health care budgets throughout the world have increased dramatically, eliciting growing pressures for cost containment. This book explores four important issues in pharmaceutical innovations: (1) the industry structure of pharmaceutical innovation; (2) incentives for correcting market failures in allocating resources for research and development; (3) competition and marketing; and (4) public evaluation of the benefits and costs of innovation. The lessons are applicable to countries all over the world, at all levels of economic development. By discussing existing evidence this book proposes incentive arrangements to accomplish social objectives.